UniProt ID | EPS8_MOUSE | |
---|---|---|
UniProt AC | Q08509 | |
Protein Name | Epidermal growth factor receptor kinase substrate 8 | |
Gene Name | Eps8 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 821 | |
Subcellular Localization | Cytoplasm, cell cortex. Cell projection, ruffle membrane. Cell projection, growth cone. Cell projection, stereocilium . Cell junction, synapse, synaptosome. Localizes at the tips of the stereocilia of the inner and outer hair cells (PubMed:24741995, | |
Protein Description | Signaling adapter that controls various cellular protrusions by regulating actin cytoskeleton dynamics and architecture. Depending on its association with other signal transducers, can regulate different processes. Together with SOS1 and ABI1, forms a trimeric complex that participates in transduction of signals from Ras to Rac by activating the Rac-specific guanine nucleotide exchange factor (GEF) activity. Acts as a direct regulator of actin dynamics by binding actin filaments and has both barbed-end actin filament capping and actin bundling activities depending on the context. Displays barbed-end actin capping activity when associated with ABI1, thereby regulating actin-based motility process: capping activity is auto-inhibited and inhibition is relieved upon ABI1 interaction. Also shows actin bundling activity when associated with BAIAP2, enhancing BAIAP2-dependent membrane extensions and promoting filopodial protrusions. Involved in the regulation of processes such as axonal filopodia growth, stereocilia length, dendritic cell migration and cancer cell migration and invasion. Acts as a regulator of axonal filopodia formation in neurons: in the absence of neurotrophic factors, negatively regulates axonal filopodia formation via actin-capping activity. In contrast, it is phosphorylated in the presence of BDNF leading to inhibition of its actin-capping activity and stimulation of filopodia formation. Component of a complex with WHRN and MYO15A that localizes at stereocilia tips and is required for elongation of the stereocilia actin core. Indirectly involved in cell cycle progression; its degradation following ubiquitination being required during G2 phase to promote cell shape changes.. | |
Protein Sequence | MNGHMSNRSSGYGVYPSQLNGYGSSPPYSQMDREHSSRTSAKALYEQRKNYARDSVSSVSDVSQYRVEHLTTFVLDRKDAMITVEDGIRKLKLLDAKGKVWTQDMILQVDDRAVSLIDLESKNELENFPLNTISHCQAVVHACSYDSILALVCKEPTQSKPDLHLFQCDEVKANLISEDIESAISDSKGGKQKRRPEALRMIAKADPGIPPPPRAPAPVPPGTVTQVDVRSRVAAWSAWAADQGDFEKPRQYHEQEETPEMMAARIDRDVQILNHILDDIEFFITKLQKAAEAFSELSKRKKSKKSKRKGPGEGVLTLRAKPPPPDEFVDCFQKFKHGFNLLAKLKSHIQNPSASDLVHFLFTPLNMVVQATGGPELASSVLSPLLTKDTVDFLNYTATAEERKLWMSLGDSWVKVRAEWPKEQFIPPYVPRFRNGWEPPMLNFMGAPTEQDMYQLAESVANAEHQRKQDSKRLSTEHSNVSDYPPADGYAYSSSMYHRGPHADHGEAAMPFKSTPNHQVDRNYDAVKTQPKKYAKSKYDFVARNSSELSVMKDDVLEILDDRRQWWKVRNASGDSGFVPNNILDIMRTPESGVGRADPPYTHTIQKQRTEYGLRSADTPSAPSPPPTPAPVPVPLPPSVPAPVSVPKVPANVTRQNSSSSDSGGSIVRDSQRYKQLPVDRRKSQMEEVQDELFQRLTIGRSAAQRKFHVPRQNVPVINITYDSSPEEVKTWLQSKGFNPVTVNSLGVLNGAQLFSLNKDELRSVCPEGARVFNQITVQKAALEDSNGSSELQEIMRRRQEKISAAASDSGVESFDEGSSH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
15 | Phosphorylation | RSSGYGVYPSQLNGY CCCCCCCCHHHCCCC | 7.87 | 29514104 | |
22 | Phosphorylation | YPSQLNGYGSSPPYS CHHHCCCCCCCCCHH | 16.86 | 29514104 | |
25 | Phosphorylation | QLNGYGSSPPYSQMD HCCCCCCCCCHHHCC | 26.07 | 29514104 | |
28 | Phosphorylation | GYGSSPPYSQMDREH CCCCCCCHHHCCCHH | 18.21 | 29514104 | |
29 | Phosphorylation | YGSSPPYSQMDREHS CCCCCCHHHCCCHHC | 25.46 | 29514104 | |
45 | Phosphorylation | RTSAKALYEQRKNYA HHHHHHHHHHHHHHC | 18.18 | 25367039 | |
55 | Phosphorylation | RKNYARDSVSSVSDV HHHHCHHCCCCHHHH | 20.53 | 29899451 | |
57 | Phosphorylation | NYARDSVSSVSDVSQ HHCHHCCCCHHHHHH | 29.04 | 26370283 | |
58 | Phosphorylation | YARDSVSSVSDVSQY HCHHCCCCHHHHHHH | 24.39 | 30635358 | |
60 | Phosphorylation | RDSVSSVSDVSQYRV HHCCCCHHHHHHHHH | 33.95 | 30635358 | |
63 | Phosphorylation | VSSVSDVSQYRVEHL CCCHHHHHHHHHHHE | 26.87 | 30635358 | |
185 | Phosphorylation | EDIESAISDSKGGKQ HHHHHHHHCCCCCCC | 35.23 | - | |
187 | Phosphorylation | IESAISDSKGGKQKR HHHHHHCCCCCCCCC | 26.81 | - | |
223 | Phosphorylation | PAPVPPGTVTQVDVR CCCCCCCCEEEEECH | 26.59 | 25619855 | |
295 | Phosphorylation | QKAAEAFSELSKRKK HHHHHHHHHHHHHHH | 44.68 | 19854140 | |
298 | Phosphorylation | AEAFSELSKRKKSKK HHHHHHHHHHHHCCC | 26.77 | 29514104 | |
317 | Phosphorylation | GPGEGVLTLRAKPPP CCCCCEEEEEECCCC | 16.28 | 27180971 | |
475 | Phosphorylation | KQDSKRLSTEHSNVS HHHHHCCCCCCCCCC | 35.46 | 28638064 | |
476 | Phosphorylation | QDSKRLSTEHSNVSD HHHHCCCCCCCCCCC | 42.16 | 26643407 | |
479 | Phosphorylation | KRLSTEHSNVSDYPP HCCCCCCCCCCCCCC | 32.47 | 26643407 | |
482 | Phosphorylation | STEHSNVSDYPPADG CCCCCCCCCCCCCCC | 35.36 | 26643407 | |
484 | Phosphorylation | EHSNVSDYPPADGYA CCCCCCCCCCCCCCE | 12.01 | 18563927 | |
490 | Phosphorylation | DYPPADGYAYSSSMY CCCCCCCCEECCCCC | 11.69 | 25777480 | |
492 | Phosphorylation | PPADGYAYSSSMYHR CCCCCCEECCCCCCC | 10.70 | 25777480 | |
493 | Phosphorylation | PADGYAYSSSMYHRG CCCCCEECCCCCCCC | 14.04 | 25777480 | |
494 | Phosphorylation | ADGYAYSSSMYHRGP CCCCEECCCCCCCCC | 13.37 | 25777480 | |
495 | Phosphorylation | DGYAYSSSMYHRGPH CCCEECCCCCCCCCC | 19.88 | 25777480 | |
497 | Phosphorylation | YAYSSSMYHRGPHAD CEECCCCCCCCCCCC | 7.13 | 25777480 | |
514 | Phosphorylation | EAAMPFKSTPNHQVD CCCCCCCCCCCCCCC | 49.85 | 25777480 | |
524 | Phosphorylation | NHQVDRNYDAVKTQP CCCCCCCHHHHHCCC | 13.23 | 20116462 | |
534 | Phosphorylation | VKTQPKKYAKSKYDF HHCCCHHHHHCHHCE | 25.95 | - | |
539 | Phosphorylation | KKYAKSKYDFVARNS HHHHHCHHCEECCCC | 23.00 | 28418008 | |
546 | Phosphorylation | YDFVARNSSELSVMK HCEECCCCCCCCEEC | 21.45 | 27180971 | |
547 | Phosphorylation | DFVARNSSELSVMKD CEECCCCCCCCEECH | 46.21 | 29472430 | |
573 | Phosphorylation | WWKVRNASGDSGFVP HEEEECCCCCCCCCC | 46.83 | 27180971 | |
601 | Phosphorylation | VGRADPPYTHTIQKQ CCCCCCCCCCCCCCC | 19.28 | 25367039 | |
602 | Phosphorylation | GRADPPYTHTIQKQR CCCCCCCCCCCCCCC | 20.51 | 25367039 | |
604 | Phosphorylation | ADPPYTHTIQKQRTE CCCCCCCCCCCCCCH | 19.80 | 29514104 | |
610 | Phosphorylation | HTIQKQRTEYGLRSA CCCCCCCCHHCCCCC | 30.94 | 25367039 | |
612 | Phosphorylation | IQKQRTEYGLRSADT CCCCCCHHCCCCCCC | 22.35 | 25367039 | |
616 | Phosphorylation | RTEYGLRSADTPSAP CCHHCCCCCCCCCCC | 35.22 | 25619855 | |
619 | Phosphorylation | YGLRSADTPSAPSPP HCCCCCCCCCCCCCC | 20.89 | 25619855 | |
621 | Phosphorylation | LRSADTPSAPSPPPT CCCCCCCCCCCCCCC | 55.71 | 25619855 | |
624 | Phosphorylation | ADTPSAPSPPPTPAP CCCCCCCCCCCCCCC | 50.16 | 27087446 | |
628 | Phosphorylation | SAPSPPPTPAPVPVP CCCCCCCCCCCCCCC | 37.54 | 22942356 | |
639 | Phosphorylation | VPVPLPPSVPAPVSV CCCCCCCCCCCCCCC | 38.50 | 25619855 | |
645 | Phosphorylation | PSVPAPVSVPKVPAN CCCCCCCCCCCCCCC | 31.48 | 25619855 | |
654 | Phosphorylation | PKVPANVTRQNSSSS CCCCCCCCCCCCCCC | 26.75 | 26643407 | |
658 | Phosphorylation | ANVTRQNSSSSDSGG CCCCCCCCCCCCCCC | 24.21 | 25521595 | |
659 | Phosphorylation | NVTRQNSSSSDSGGS CCCCCCCCCCCCCCC | 41.22 | 23684622 | |
660 | Phosphorylation | VTRQNSSSSDSGGSI CCCCCCCCCCCCCCC | 37.68 | 23375375 | |
661 | Phosphorylation | TRQNSSSSDSGGSIV CCCCCCCCCCCCCCC | 37.43 | 25521595 | |
663 | Phosphorylation | QNSSSSDSGGSIVRD CCCCCCCCCCCCCCC | 47.18 | 27087446 | |
666 | Phosphorylation | SSSDSGGSIVRDSQR CCCCCCCCCCCCCHH | 22.80 | 29514104 | |
671 | Phosphorylation | GGSIVRDSQRYKQLP CCCCCCCCHHHHCCC | 13.14 | 29899451 | |
674 | Phosphorylation | IVRDSQRYKQLPVDR CCCCCHHHHCCCCHH | 8.75 | 25367039 | |
683 | Ubiquitination | QLPVDRRKSQMEEVQ CCCCHHHHHHHHHHH | 46.03 | - | |
684 | Phosphorylation | LPVDRRKSQMEEVQD CCCHHHHHHHHHHHH | 32.71 | 25521595 | |
725 | Phosphorylation | INITYDSSPEEVKTW EEEEECCCHHHHHHH | 33.17 | 25521595 | |
786 | Phosphorylation | QKAALEDSNGSSELQ EHHHHHCCCCCHHHH | 33.44 | 19060867 | |
789 | Phosphorylation | ALEDSNGSSELQEIM HHHCCCCCHHHHHHH | 25.53 | 30635358 | |
790 | Phosphorylation | LEDSNGSSELQEIMR HHCCCCCHHHHHHHH | 43.66 | 30635358 | |
804 | Phosphorylation | RRRQEKISAAASDSG HHHHHHHHHHHHCCC | 23.95 | 25619855 | |
808 | Phosphorylation | EKISAAASDSGVESF HHHHHHHHCCCCCCC | 27.81 | 25619855 | |
810 | Phosphorylation | ISAAASDSGVESFDE HHHHHHCCCCCCCCC | 42.09 | 27087446 | |
814 | Phosphorylation | ASDSGVESFDEGSSH HHCCCCCCCCCCCCC | 35.27 | 27087446 | |
819 | Phosphorylation | VESFDEGSSH----- CCCCCCCCCC----- | 24.16 | 25619855 | |
820 | Phosphorylation | ESFDEGSSH------ CCCCCCCCC------ | 44.03 | 25619855 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
497 | Y | Phosphorylation | Kinase | BRK | Q64434 | PSP |
524 | Y | Phosphorylation | Kinase | BRK | Q64434 | PSP |
534 | Y | Phosphorylation | Kinase | BRK | Q64434 | PSP |
624 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
624 | S | Phosphorylation | Kinase | MAPK | - | Uniprot |
628 | T | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
628 | T | Phosphorylation | Kinase | MAPK | - | Uniprot |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EPS8_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CBL_MOUSE | Cbl | physical | 7517397 | |
NMDZ1_MOUSE | Grin1 | physical | 17018287 | |
NMDE1_MOUSE | Grin2a | physical | 17018287 | |
NMDE3_MOUSE | Grin2c | physical | 17018287 | |
P85A_MOUSE | Pik3r1 | physical | 12515821 | |
ABI1_MOUSE | Abi1 | physical | 12515821 | |
SOS1_MOUSE | Sos1 | physical | 12515821 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...